Intravitreal Bevacizumab for Radiation-Induced Cystoid Macular Oedema in Patients with Nasopharyngeal Carcinoma: A Clinical Series

Publisher： Karger

E-ISSN： 1423-0267|229|4|208-211

ISSN： 0030-3755

Source： Ophthalmologica, Vol.229, Iss.4, 2013-03, pp. : 208-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema

By  

Ocular Oncology and Pathology, Vol. 3, Iss. 3, 2017-01 ,pp. : 168-175

Karger

Access to resources Recommend Favorite

Prospective Pilot Study: Efficacy of Intravitreal Dexamethasone and Bevacizumab Injections in the Treatment of Macular Oedema Associated with Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-05 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema

By  

Ophthalmic Research, Vol. 56, Iss. 4, 2016-05 ,pp. : 207-214

Karger

Access to resources Recommend Favorite

Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 2, 2016-09 ,pp. : 389-397

Karger

Access to resources Recommend Favorite

The Effectiveness of Intravitreal Ranibizumab in Patients with Diabetic Macular Edema Who Have Failed to Respond to Intravitreal Bevacizumab

By  

Ophthalmologica, Vol. 235, Iss. 3, 2016-03 ,pp. : 133-136

Karger

Access to resources Recommend Favorite